NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ABMD - Abiomed Inc

Abiomed, Inc. is a provider of medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. The products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and/or in the heart surgery s","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ABMDhart

Abiomed Inc News


Review: OraSure Technologies Gapped Up On FDA Approval (TQNT, OSUR, COGO, ABMD)
The Mumbai Times - May 18, 2012
TriQuint Semiconductor Inc (NASDAQ:TQNT) shares were trading at $5.11 while reporting down 2.29% from yesterdays close. The 8 analysts offering 12-month price forecasts for TriQuint Semiconductor Inc have a median target of 5.50, with a high estimate ...

MKM Partners Raises Price Target on Abiomed (ABMD)
Daily Political - May 18, 2012
Equities researchers at MKM Partners upped their target price on shares of Abiomed (NASDAQ: ABMD) from $27.00 to $29.00 in a report issued on Thursday.

6 Highly Shorted Takeover/LBO Targets Being Bought By Hedge Funds
Seeking Alpha - May 18, 2012
When a company announces that it is being taken over or acquired, its stock price usually jumps to reflect the takeover premium being paid for the company.

Abiomed says 2012 was 'best year in company history'
Mass High Tech - May 17, 2012
By Don Seiffert Abiomed Inc. (Nasdaq:ABMD), a medical device company in Danvers focused on heart support technologies, announced its first full year of profitability in 2012, and raised its revenue expectations for fiscal 2013.

Equities Research Analysts' Price Target Changes for May, 17th (ABMD, ANF, DE ...
Junction Report - May 17, 2012
Abiomed (NASDAQ: ABMD) had its price target raised by analysts at Wunderlich from $27.00 to $29.00. They now have a “buy” rating on the stock.

U.S. Companies Reporting Earnings on May 16
Bloomberg - May 16, 2012
The following table lists the 38 US companies that reported quarterly earnings today (end date of the quarter is noted in the last column).
US Companies Reporting Earnings on May 16 - BusinessWeek

Downward Drift (DE, JCP, ANF, ABMD, SINA, URZ)
tickerspy Newswire - May 16, 2012
by Geoff Seiler | May 16th | Filed in: Stock Analysis Stocks continued their downward trend, brushing off some solid economic data.

Highs & Lows: AOL, Banco Santander, and Lennar
Schaeffers Research (blog) - May 16, 2012
by Jim Cunningham 5/16/2012 2:31 PM The major market indexes are battling breakeven this afternoon, torn between upbeat housing and industrial production data and ongoing political tension in Greece.

Deere & Co., Target Net Up; Abercrombie & Fitch, Staples Net Fall
123Jump.com - May 16, 2012
10:45 AM New York - Abercrombie & Fitch first quarter net tumbled 88% to $3 million. Abiomed fourth quarter net income swung to $2.57 million.

Earnings Releases: ABMD, ANF, BRC, CHS, CTRN, DE, EXP, FPO, SPLS, TGT, VVTV
Movie News Guide (blog) - May 16, 2012
Abiomed (ABMD) issued its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.07.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>